Tag: prostate cancer
Five-year outcomes show transurethral ultrasound ablation successful in treatment of prostate...
A minimally invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation is effective in treating prostate cancer, according to new research...
First patient treated in VAPOR 2 pivotal study for water vapour...
Francis Medical, Inc, a privately held medical device company developing an innovative and proprietary water vapour ablation therapy for the treatment of prostate, kidney,...
Postmarket study will evaluate CLS Tranberg thermal therapy system
Clinical Laserthermia Systems Americas (CLS) and HALO Precision Diagnostics (HALO) have announced a letter of intent to evaluate the safety and short-term efficacy of...
Insightec receives FDA IDE approval for prostate cancer comparative study using...
Insightec, a global healthcare company dedicated to using acoustic energy to transform patient care, announced that it has received US Food and Drug Administration...
CLS Americas debuts fusion-guided TRANBERG focal laser ablation system at AUA...
CLS Americas announced it will debut its office-based, magnetic resonance (MR)/ultrasound (US) fusion-guided, TRANBERG Thermal Therapy System for high-precision focal laser ablation of soft...
Novel use of Y-90 radioembolization could transform prostate cancer treatment
In an entirely new endeavour for Yttrium-90 (Y-90) radioembolization, investigators from Northwestern University, Chicago, USA, have used the technique for the treatment of prostate...
HIFU shows outcomes in line with surgery for significant nonmetastatic prostate...
SonaCare Medical has reported five-year outcomes from a multicentre study of 625 medium to high-risk clinically significant nonmetastatic prostate cancer patients following focal therapy...
MagForce gets US FDA nod to begin clinical trial evaluating focal...
The US FDA’s granting of an investigational device exemption (IDE) allows MagForce to conduct a pivotal clinical evaluating the company’s NanoTherm therapy for intermediate...
Irreversible electroporation has “potential to become new standard of care” in...
A new study presented at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE 2016, 10–14 September, Barcelona, Spain) meeting finds that the treatment...
